# Helpful Articles **URL:** \ **Category:** Life with Primary Sclerosing Cholangitis\ **Created:** [November 16, 2017, 7:06pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873 "2017-11-16T19:06:48Z")\ **Posts on this page:** 12\ **Page:** 1
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:06pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/1 "2017-11-16T19:06:48Z")
I am going to share some articles that I have found helpful. They cover different aspects of PSC. Feel free to share articles or other resources that have helped you. ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:07pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/2 "2017-11-16T19:07:58Z")
**Primary sclerosing cholangitis – a comprehensive review** [http://www.journal-of-hepatology.eu/article/S0168-8278(17)32196-7/pdf](http://www.journal-of-hepatology.eu/article/S0168-8278(17)32196-7/pdf) ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:12pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/3 "2017-11-16T19:12:48Z")
**Pathogenesis and clinical spectrum of primary sclerosing cholangitis** > **[Pathogenesis and clinical spectrum of primary sclerosing cholangitis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394509/)** > > Primary sclerosing cholangitis (PSC) is a disease of the biliary tract, which has been documented in the literature since 1867. This disease has a strong predilection for affecting men and can be seen in individuals as young as 2 years of age. PSC... ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:14pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/4 "2017-11-16T19:14:11Z")
**Primary sclerosing cholangitis: diagnostic and management challenges** > **[\[Full text\] Primary sclerosing cholangitis: diagnostic and management...](https://www.dovepress.com/primary-sclerosing-cholangitis-diagnostic-and-management-challenges-peer-reviewed-fulltext-article-CEG)** > > Primary sclerosing cholangitis: diagnostic and management challenges Sanjeev Sirpal,1 Natasha Chandok2 1Department of Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Montreal, QC, 2Department of Medicine,... ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:16pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/5 "2017-11-16T19:16:30Z")
**The gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease** > **[Review article: the gut microbiome as a therapeutic target in the...](https://onlinelibrary.wiley.com/doi/full/10.1111/apt.14397)** > > Background > Mortality from chronic liver disease is rising exponentially. The liver is intimately linked to the gut via the portal vein, and exposure to gut microbiota and their metabolites transloca... ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:17pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/6 "2017-11-16T19:17:49Z")
**PRIMARY SCLEROSING CHOLANGITIS IN CHILDREN AND ADOLESCENTS** [http://www.scielo.br/scielo.php?script=sci\_arttext&pid=S0004-28032017005011101&lng=en&nrm=iso&tlng=en](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032017005011101&lng=en&nrm=iso&tlng=en) ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:19pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/7 "2017-11-16T19:19:13Z")
**Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis** > **[Distinct gut microbiota profiles in patients with primary sclerosing...](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504370/)** > > To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC).Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with (n = 32)... ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:20pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/8 "2017-11-16T19:20:34Z")
**New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis** > **[New approach to decrease post-ERCP adverse events in patients with primary...](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546902/)** > > Endoscopic retrograde cholangiopancreatography (ERCP) is often performed in patients with primary sclerosing cholangitis (PSC). Our aim was to validate a treatment approach with the objective of decreasing ERCP related adverse events (AEs). > > All... ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:22pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/9 "2017-11-16T19:22:25Z")
**Endoscopic Management of Primary Sclerosing Cholangitis** > **[213827.pdf](https://publisherspanel.com/api/files/view/213827.pdf)** ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:23pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/10 "2017-11-16T19:23:24Z")
**Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia** > **[Bile microbiota in primary sclerosing cholangitis: Impact on disease...](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552186/)** > > The etiopathogenesis and risk for development of biliary neoplasia in primary sclerosing cholangitis (PSC) are largely unknown. Microbes or their metabolites have been suggested to play a role. To explore this potential microbial involvement, we... ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:25pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/11 "2017-11-16T19:25:57Z")
**The “gut microbiota” hypothesis in primary sclerosing cholangitis** [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233520/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233520/) ---
**Author:** ![Friend](https://avatars.discourse-cdn.com/v4/letter/f/59ef9b/32.png) [@Friend](https://forum.livingwithpsc.org/u/Friend)\ **Post date:** [November 16, 2017, 7:27pm UTC](https://forum.livingwithpsc.org/t/helpful-articles/1873/12 "2017-11-16T19:27:15Z")
**Common controversies in management of biliary strictures** > **[Common controversies in management of biliary strictures](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323437/)** > > Biliary strictures are caused by a heterogeneous group of benign and malignant conditions, each requiring a specific treatment approach. Management of biliary strictures often involves endoscopy either for definite treatment, as a bridge to surgery...